B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.

about

Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation."B cells and autoimmunity 2016".

P2860

Q33752808-4C4BFDCA-5249-4381-B427-3FE3489DE30B Q53802747-5771BE97-EBBD-4997-B3A9-7A8C77A20841

P2860

B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.

Item

http://www.wikidata.org/entity/Q38961202

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.

@en

type

Item

label

B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.

@en

prefLabel

B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.

@en

P1476

B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases

@en

P2093

Jean-Frederic Colombel

http://www.w3.org/2001/XMLSchema#string

Saurabh Mehandru

http://www.w3.org/2001/XMLSchema#string

P2860

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation

NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily

The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease

Characterization of antigen receptor response elements within the interleukin-2 enhancer

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

NFAT: ubiquitous regulator of cell differentiation and adaptation

B-cell survival factors in autoimmune rheumatic disorders

BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator

Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI

P2888

s10620-016-4317-9

P304

3407-3424

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10620-016-4317-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrea Cerutti

Xavier Tréton

Mathieu Uzzan

P577

2016-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1043944306

http://www.w3.org/2001/XMLSchema#string

P698

27655102

http://www.w3.org/2001/XMLSchema#string

B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.

about

P2860

P2860

B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698